Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
| DRUGNAME | PT | EventCount |
|---|---|---|
| RITUXIMAB | Haemolytic anaemia | 3 |
| RITUXIMAB | Haemorrhage | 3 |
| Rituximab | Hepatic fibrosis | 3 |
| Rituximab | Herpes ophthalmic | 3 |
| RITUXIMAB | Hospitalisation | 3 |
| rituximab | Hot flush | 3 |
| RITUXIMAB | Hypersensitivity vasculitis | 3 |
| Rituximab | Hypocalcaemia | 3 |
| Rituximab | Ileus | 3 |
| Rituximab | Impaired healing | 3 |
| RITUXIMAB | Infection reactivation | 3 |
| RITUXIMAB | Injection site reaction | 3 |
| Rituximab | Invasive breast carcinoma | 3 |
| Rituximab | Invasive ductal breast carcinoma | 3 |
| Rituximab | Lipids abnormal | 3 |
| rituximab | Localised oedema | 3 |
| Rituximab | Lung adenocarcinoma | 3 |
| Rituximab | Lymphocyte count decreased | 3 |
| Rituximab | Malnutrition | 3 |
| RITUXIMAB | Mantle cell lymphoma recurrent | 3 |
Total Records: 1,104 Number of Pages: 56